My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 156

    1.

    Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide.

    Adams JS, Song CF, Kantorovich V.

    Ann Intern Med. 1999 Apr 20;130(8):658-60.PMID: 10215562 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Bone mineral density changes in hypercalciuretic osteoporotic men treated with thiazide diuretics.

    Legroux-Gerot I, Catanzariti L, Marchandise X, Duquesnoy B, Cortet B.

    Joint Bone Spine. 2004 Jan;71(1):51-5.PMID: 14769521 [PubMed - indexed for MEDLINE]Related articles

    3.

    Gains in bone mineral density with resolution of vitamin D intoxication.

    Adams JS, Lee G.

    Ann Intern Med. 1997 Aug 1;127(3):203-6.PMID: 9245225 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women.

    Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR.

    Osteoporos Int. 2007 Apr;18(4):479-86. Epub 2006 Nov 21.PMID: 17120180 [PubMed - indexed for MEDLINE]Related articles

    5.

    Beneficial effect of a thiazide diuretic on bone mineral density in male osteoporosis with hypercalciuria.

    Laroche M, Mazières B.

    Clin Exp Rheumatol. 1998 Jan-Feb;16(1):109-10. No abstract available. PMID: 9543581 [PubMed - indexed for MEDLINE]Related articles

    6.

    Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial.

    Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne AM, Evans MC, Murray MA, McNeil AR, Gamble GD.

    Am J Med. 2000 Oct 1;109(5):362-70.PMID: 11020392 [PubMed - indexed for MEDLINE]Related articles

    7.

    Sodium transport and bone mineral density in hypercalciuria with thiazide treatment.

    Reusz GS, Dobos M, Vásárhelyi B, Sallay P, Szabó A, Horváth C, Szabó A, Byrd DJ, Thole HH, Tulassay T.

    Pediatr Nephrol. 1998 Jan;12(1):30-4.PMID: 9502564 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bone mineral density in children with myelomeningocele: effect of hydrochlorothiazide.

    Quan A, Adams R, Ekmark E, Baum M.

    Pediatr Nephrol. 2003 Sep;18(9):929-33. Epub 2003 Jul 23.PMID: 12883972 [PubMed - indexed for MEDLINE]Related articles

    9.

    Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial.

    LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE.

    Ann Intern Med. 2000 Oct 3;133(7):516-26.PMID: 11015164 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [Idiopathic hypercalciuria in childhood]

    Reusz G.

    Orv Hetil. 1998 Dec 6;139(49):2957-62. Review. Hungarian. PMID: 9879200 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.

    Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD.

    J Urol. 2003 Feb;169(2):465-9.PMID: 12544288 [PubMed - indexed for MEDLINE]Related articles

    12.

    Thiazide diuretics and osteoporosis.

    [No authors listed]

    Mayo Clin Health Lett. 2002 May;20(5):4. No abstract available. PMID: 16136626 [PubMed - indexed for MEDLINE]Related articles

    13.

    Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

    Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP.

    J Clin Endocrinol Metab. 2000 Sep;85(9):3069-76.PMID: 10999788 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.

    Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM.

    N Engl J Med. 2003 Sep 25;349(13):1216-26. Epub 2003 Sep 20.PMID: 14500805 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria.

    Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY.

    Osteoporos Int. 1992 May;2(3):128-34.PMID: 1627899 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.

    Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.

    Clin Rheumatol. 2005 Jun;24(3):232-8. Epub 2005 Jan 13.PMID: 15647969 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene.

    Sato K, Hasegawa Y, Nakae J, Nanao K, Takahashi I, Tajima T, Shinohara N, Fujieda K.

    J Clin Endocrinol Metab. 2002 Jul;87(7):3068-73.PMID: 12107202 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Alendronate for the treatment of osteoporosis in men.

    Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A.

    N Engl J Med. 2000 Aug 31;343(9):604-10.PMID: 10979796 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria.

    Vezzoli G, Rubinacci A, Bianchin C, Arcidiacono T, Giambona S, Mignogna G, Fochesato E, Terranegra A, Cusi D, Soldati L.

    Am J Kidney Dis. 2003 Dec;42(6):1177-83.PMID: 14655189 [PubMed - indexed for MEDLINE]Related articles

    20.

    Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.

    Biermasz NR, Hamdy NA, Janssen YJ, Roelfsema F.

    J Clin Endocrinol Metab. 2001 Jul;86(7):3079-85.PMID: 11443170 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity